Bone Specific Alk Phosphatase ALKPBONE

Synonyms

Allscripts (AEHR) Order Name

Bone Specific Alk Phosphatase

Sunrise Clinical Manager (SCM) Order Name

Bone Specific Alk Phosphatase

Clinical Info

Quantitative measurement of skeletal alkaline phosphatase to be used as an aid in the management of patients with Paget disease and osteoporosis

Specimen Type

Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube:  Gold top Tube
Specimen:  1 mL serum ( 0.5 mL min)
Transport Temperature: Refrigerated
Stability:  14 Days  Room Temperature, Refrigerated or Frozen
Collection: Separate serum from cells within 45 minutes of collection

Transport Instructions

Refrigerated

Specimen Stability

14 Days  Room Temperature, Refrigerated or Frozen
Collection: Separate serum from cells within 45 minutes of collection

Methodology

Immunochemiluminometric assay (ICMA)
 
TAT: 3 - 6 Days

Days Performed

Performing Laboratory

LabCorp Burlington

CPT

84080
 
LOINC Code: 17838-4

PDM

5916080

Result Interpretation

Age	Male (μg/L)	Female (μg/L)
0 to 5 m	Not established	Not established
6 to 11 m	48.2−170.2	50.4−154.0
1 y	41.9−229.6	44.2−178.3
2 y	41.7−139.4	34.9−195.4
3 to 4 y	37.2−127.7	37.4−96.8
5 to 6 y	42.0−104.2	31.4−100.8
7 to 8 y	59.0−101.3	44.0−135.8
9 to 10 y	50.4−133.0	47.9−150.8
11 to 12 y	53.3−156.8	24.2−133.3
13 to 14 y	77.5−169.8	19.8−92.7
15 to 16 y	26.8−173.4	11.2−30.2
17 to 18 y	15.4−69.8	8.8−29.0
19 to 20 y	12.2−36.6	7.7−16.8
21 to 29 y	7.4−27.7	See below
30 to 34 y	7.0−27.4	See below
35 to 39 y	4.0−27.0	See below
40 to 44 y	7.4−26.7	See below
45 to 49 y	7.5−26.4	See below
50 to 54 y	7.5−26.1	See below
55 to 59 y	7.5−25.7	See below
60 to 64 y	7.5−25.4	See below
65 to 69 y	7.6−25.1	See below
70 to 74 y	7.6−24.8	See below
75 to 100 y	7.6−24.4	See below
Female
Premenopausal: 6.0−22.7 μg/L
Postmenopausal: 8.1−31.6 μg/L

Forms